How Is DENTSPLY SIRONA Inc. (XRAY)’s Price-To-Earnings Ratio?


As of Wednesday close, DENTSPLY SIRONA Inc.’s (NASDAQ:XRAY) stock was down -$0.17, moving down -0.52 percent to $32.77. The average number of shares traded per day over the past five days has been 1,969,680 shares. 2 times new highs have been achieved over the past 5 days, with a -$1.59 fall in that time frame. In the last twenty days, the average volume was 2,015,725, while in the previous 50 days, it was 1,764,392.

Since last month, XRAY stock retreated -7.87%. Shares of the company fell to $32.52 on 08/30/22, the lowest level in the past month. A 52-week high of $63.10 was reached on 02/25/22 after having rallying from a 52-week low of $32.52. Since the beginning of this year, XRAY’s stock price has dropped by -41.26% or -$23.02, and marked a new high 4 times. However, the stock has declined by -48.07% since its 52-week high.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


DENTSPLY SIRONA Inc. (XRAY) last reported insider trading activity 121 days ago on May 03. BRANDT ERIC, the Director of the company, disposed of 6,900 shares for $39.71 on May 03. It resulted in a $273,999 divestment by the insider. Casey Donald M Jr. added 20,000 shares at an average price of $49.78 on Dec 01. The insider now owns 52,500 shares following the transaction. On Nov 19, Sr VP & Chief HR Officer Yankie Lisa sold 1,903 shares at $52.63 apiece. The transaction was valued at $100,155.

Valuation Metrics

Right now, DENTSPLY SIRONA Inc. (XRAY) has a P/E ratio of about 19.49. The stock’s beta is 0.91. Besides these, the trailing price-to-sales (P/S) ratio of 1.74, the price-to-book (PB) ratio of 1.42, and the price-to-cash flow ratio of 15.20 may also be considered.

The latest dividend of $0.1250 per share was paid out, remained unchanged from last year’s $0.1250. On Thursday March 3 2022, a $0.0150 dividend increase was announced.

Financial Health

In the three months ended March 30, DENTSPLY SIRONA Inc.’s quick ratio stood at 1.10, while its current ratio was 1.50, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending March 30 was 0.38, and the total debt-to-equity ratio was 0.42. On the profitability front, the trailing twelve-month gross margin is 54.80% percent. In the year ended March 30, operating margins totaled 14.70%. Based on annual data, XRAY earned $2.36 billion in gross profit and brought in $4.25 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 6.90%. Return on equity (ROE) for the past 12 months was 8.30%.

In DENTSPLY SIRONA Inc.’s quarter-end financial report for March 30, it reported total debt of $1.91 billion. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. XRAY’s revenue rose 17.76% to $1.07 billion during the quarter, while net income inched up to $1.09 billion. While analysts expected DENTSPLY SIRONA Inc. to report $0.56 quarterly earnings, the actual figure was $0.52 per share, beating the consensus estimate by -7.10%. The liabilities of DENTSPLY SIRONA Inc. were 4.25 billion at the end of its most recent quarter ended March 30, and its total debt was $2.38 billion.

Technical Picture

This quick technical analysis looks at DENTSPLY SIRONA Inc.’s (XRAY) price momentum. With a historical volatility rate of 21.95%, the RSI 9-day stood at 24.30% on 31 August.

With respect to its five-day moving average, the current DENTSPLY SIRONA Inc. price is down by -4.63% percent or -$1.59. At present, XRAY shares trade -8.72% below its 20-day simple moving average and -31.83% percent below its 100-day simple moving average. However, the stock is currently trading approximately -6.85% below its SMA50 and -40.34% below its SMA200.

Stochastic coefficient K was 4.75% and Stochastic coefficient D was 5.43%, while ATR was 0.88. Given the Stochastic reading of 4.73% for the 14-day period, the RSI (14) reading has been calculated as 30.40%. As of today, the MACD Oscillator reading stands at -1.08, while the 14-day reading stands at -2.08.

Analyst Ratings

DENTSPLY SIRONA Inc. downgraded its rating on DENTSPLY SIRONA Inc. (NASDAQ: XRAY) to an Underperform in a note to investors on August 05, 2022. The analysts firm previously had a Mkt perform rating on the stock.DENTSPLY SIRONA Inc. (XRAY) has been rated Overweight by analysts. According to 1 brokerage firm, XRAY is a sell, and 4 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate DENTSPLY SIRONA Inc. stock as buy, with 5 recommending it as overweight.

With a median target price of $42.00, the current consensus forecast for the stock is $38.00 – $51.00. Based on these forecasts, analysts predict DENTSPLY SIRONA Inc. (XRAY) will achieve an average price target of $43.00.


Please enter your comment!
Please enter your name here